Elocta (Efmoroctocog alfa Vials) 500 IE

Elocta (efmoroctocog alfa) is a recombinant factor VIII therapy in vials, used for hemophilia A treatment. This single-dose vial provides 500 IU of clotting factor for intravenous use. Store between 2-8°C to maintain potency. A trusted option for bleeding disorder management.

Strength

500 IE

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Swedish Orphan Biovitrum

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Elocta is used to prevent and control bleeding episodes in patients with hemophilia A. It works by replacing missing clotting factor VIII, helping blood to clot properly. This medication is prescribed for routine prophylaxis as well as on-demand treatment of bleeds. It may also be used before medical procedures to reduce bleeding risk.

Side Effects

Elocta helps restore normal clotting function in patients with hemophilia A. After administration, it works within the bloodstream to support proper coagulation. Users may experience improved bleeding control and reduced frequency of spontaneous bleeds with regular use. Individual responses to treatment may vary based on dosing and condition severity.

Precautions & Warnings

Keep Elocta vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Use the product only if the solution is clear and colorless. Dispose of any unused medication properly according to local guidelines. Always follow your healthcare provider's instructions for storage and handling.

Avoid Interactions

Elocta has no known direct drug interactions, but always inform your doctor about all medications you are taking. Blood thinners or other therapies affecting clotting may alter its effectiveness. Avoid mixing with other intravenous solutions unless directed by a healthcare professional. Alcohol and certain herbal supplements may impact clotting function.

Frequently Asked Questions

Elocta is used to treat and prevent bleeding in patients with hemophilia A by replacing missing clotting factor VIII.

Elocta vials should be refrigerated between 2-8°C and protected from light; do not freeze or shake.

Yes, Elocta may be used before medical procedures to reduce bleeding risk in hemophilia A patients.

Elocta is approved for use in pediatric patients with hemophilia A; dosing is determined by a healthcare provider.

Contact your healthcare provider for guidance if a dose is missed; do not take extra doses without medical advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.